AI assistant
STAAR SURGICAL CO — Director's Dealing 2017
Sep 28, 2017
31996_dirs_2017-09-28_5b3d119e-5e3d-4535-aff5-dfe4086640fb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2017-09-26
Reporting Person: ANDREWS DEBORAH J (Vice President, CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-13 | Common Stock | A | 12500 | $0.00 | Acquired | 16000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-09-26 | Common Stock Options | $ | A | 25000 | Acquired | 2027-09-25 | Common Stock (25000) | Direct |
Footnotes
F1: Award of 12,500 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 11/13/2018, 1/3 of the RSUs on 11/13/2019, and the remaining 1/3 of the RSUs on 11/13/2020.
F2: The options granted become exercisable as follows: 1/3 on 11/13/2018, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 11/13/2020.
F3: The exercise price of each option granted on 9/26/17 will be the fair market value of the Common Stock of the Corporation as of the close of business on 11/13/17.